Search results for “Kidney”

About 8 results in articles

Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing articles matching Kidney — open any to read the full text, or download the PDF or XML.

Baroreflex Sensitivity, Cardiac and Kidney Remodeling and Deterioration in Vasoactive Substances Content in Blood in Experimental Model of Renovascular Hypertension. Action of Natural Flavone, Luteolin

May 2023 DOI 10.14302/issn.2574-4488.jna-23-4545
N.A. PapiashviliCorresponding author

This study aimed to analyze pharmacological actions of phenolic compound luteolin on the renal and cardiac hypertrophy, blood pressure (BP), baroreflex sensitivity (BRS), levels of epoxyeicosatrienoic acids (EETs), prostaglandin E-2 (PGE-2) and endothelin-1 (E1) in plasma in the 2 kidney - 1 clip (2…

Thyroid Function Abnormalities in Patients with Chronic Kidney Disease

Feb 2022 DOI 10.14302/issn.2574-4488.jna-21-4039
A K Al MirajCorresponding author

The function of the thyroid gland is one of the most important in the human body as it regulates the majority of the body's physiological actions. The thyroid produces hormones (T3 and T4) that have many actions including metabolism, development, protein synthesis, and the regulation of many other i…

Hepatic Cysts as a Manifestation of Polycystic Kidney Disease (Polycystic Liver Report of 2 Mother-Son Cases)

Jul 2021 DOI 10.14302/issn.2574-4488.jna-21-3887
N Osnaya-RomeroCorresponding author Unidad de investigación clínica Instituto Nacional de Pediatría.

Polycystic kidney disease is an inherited disease that can lead to high blood pressure and kidney failure. In Mexico, 4.5% of patients with kidney failure are carriers of this disease; the liver is another of the organs affected by this disease that can manifest as abdominal pain and a mass effect i…

Comparison of Dipper and Non-Dipper Hypertension Patterns According to Chronic Kidney Disease Stage

Sep 2019 DOI 10.14302/issn.2574-4488.jna-19-3008
Zeki AydinCorresponding author

Introduction Hypertension is a major cardiovascular risk factor. There is a strong relationship between blood pressure (BP) elevation and stroke, myocardial infarction, heart failure and mortality due to kidney disease. It is known that the loss of the dipping pattern in hypertension is associated w…

Reduction in Estimated Glomerular Filtration Rate in Patients with Elevated Blood Urea Nitrogen but Normal for any Other Markers of Kidney Damage

Jun 2016 DOI 10.14302/issn.2574-4488.jna-16-1008
Xiaoyong XuCorresponding author

Background: It is unclear whether patients who present with elevated blood urea nitrogen (BUN), but are normal for other markers of kidney damage, are prone to develop chronic kidney disease (CKD). This study therefore investigated estimated glomerular filtration rate (eGFR), a marker of CKD, in the…

Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats

Jun 2021 DOI 10.14302/issn.2574-4488.jna-21-3847
Snehasis JanaCorresponding author

The aim of this study was to evaluate the impact of Biofield Energy Treated/Blessed Proprietary Test Formulation and Biofield Energy Treatment/Blessing per se on kidney biomarkers on L-NAME and high fat diet (HFD)-induced cardiovascular disorders in Sprague Dawley rats. In this experiment, the funct…

Action Mechanisms and Therapeutic Targets of Renal Fibrosis

Nov 2018 DOI 10.14302/issn.2574-4488.jna-18-2443
Wei SuCorresponding author

Renal fibrosis was a chronic and progressive process affecting kidneys in chronic kidney disease (CKD), regardless of cause. Although no effective targeted therapy yet existed to retard renal fibrosis, a number of important recent advances have highlighted the cellular and molecular mechanisms under…

Acute Bilateral Hydro Nephrosis after the Use of Dapagliflozin

Feb 2016 DOI 10.14302/issn.2574-4488.jna-15-712
Bassam BerniehCorresponding author

Background Dapagliflozin; the new oral hypoglycemic agent; is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that acts by inhibiting glucose reabsorption in the proximal tubule of the nephron. Main reported side effects are osmotic diuresis, dehydration, urinary tract and genital infections. Her…

Frequently asked questions

Are these articles peer-reviewed?
Yes. Articles published at Open Access Pub go through single-blind peer review (double-blind on request) under an editorial board before publication.
Are the articles free to read?
Yes. Every article is open access — read the full text online for free and download the PDF or XML, with no paywall or subscription.
How do I cite an article?
Use the DOI shown on each result and on the article page; it is the permanent, citable link to the article.
How do I read or download an article?
Click "Read full text" to open the article HTML, or use the PDF / XML buttons on each card to download it.